TNF alpha is required for hypoxia-mediated right ventricular hypertrophy

被引:1
作者
Robert M. Smith
Joy McCarthy
Michael N. Sack
机构
[1] MRC Inter-University Cape Heart Group,Hatter Institute for Cardiology Research
[2] University of Cape Town,undefined
[3] Medical School,undefined
来源
Molecular and Cellular Biochemistry | 2001年 / 219卷
关键词
hypobaric hypoxia; TNFα; right-ventricular hypertrophy;
D O I
暂无
中图分类号
学科分类号
摘要
Hypoxia has been shown to activate the pleiotropic cytokine TNFα in the lung. TNFα in turn, is known to induce pulmonary vasoconstriction. Additional effects of this cytokine in hypoxia mediated cardiopulmonary remodeling are poorly understood. To further evaluate the role of TNFα in chronic hypoxia we exposed TNFα null (TNFα–/–) and wild-type mice to three weeks of hypobaric hypoxia (10% O2). Equivalent erythocytosis (Hematocrit increased by ≥ 40%) developed in both genetic backgrounds. In contrast, right ventricular systolic pressure increased in response to three weeks of hypoxia in the wild-type mice (≥ 75%), yet was unaltered in the TNFα–/– mice. Concomitantly right ventricular hypertrophy was attenuated in the TNFα–/– mice (35 ± 5% increase) when compared to wild-type mice (124 ± 6% increase p < 0.001, n ≥ 20). Interestingly in both strains the lung wet weights increased to a similar degree in response to hypoxia. In conclusion, our data demonstrate that TNFα is an integral autocoid in chronic hypoxia mediated right ventricular hypertrophy. Moreover, additional components of cardiopulmonary remodeling may be regulated by TNFα signaling as suggested by the negligible right ventricular systolic pressure response to hypoxia in the absence of TNFα.
引用
收藏
页码:139 / 143
页数:4
相关论文
共 109 条
[1]  
Taylor CT(1999)Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial tumor necrosis factor-alpha J Biol Chem 274 19447-19454
[2]  
Fueki N(1998)Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-latitude pulmonary edema Respir Physiol 111 301-310
[3]  
Agah A(2000)Tumor necrosis factor blockers in rheumatoid arthritis N Engl J Med 342 810-811
[4]  
Hershberg RM(1997)Anticytokine approaches in pulmonary fibrosis: Bringing factors into focus Thorax 52 294-296
[5]  
Colgan SP(1995)Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis J Clin Invest 96 250-259
[6]  
Kubo K(1994)Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice Eur Respir J 7 515-518
[7]  
Hanaoka M(2000)Tumor necrosis factor in myocardial hypertrophy and ischaemia - an anti-apoptotic perspective Cardiovasc Res 45 688-695
[8]  
Hayano T(1997)Characterization of tumor necrosis factor-deficient mice Proc Natl Acad Sci USA 94 8093-8098
[9]  
Miyahara T(1996)Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: Role for nuclear receptors in cardiac and brown adipose tissue expression Mol Cell Biol 16 4043-4051
[10]  
Hachiya T(1992)Effect of tumor necrosis factor on hypoxic pulmonary fasoconstriction J Appl Physiol 72 1044-1049